CMS 340B cuts, UPS cold chain, and a $500M imaging deal
Supply Chain Pulse — 2026-07-17
CMS just proposed slashing 340B pharmaceutical reimbursements in its 2027 outpatient payment rule — and for the 2,500+ hospitals in the program, that's a direct hit to drug procurement economics that could reshape formulary and sourcing decisions fast. Layer on a $48M UPS cold-chain expansion and a $500M GE HealthCare imaging overhaul at Catholic Health, and today's stories sketch a clear picture: capital is flowing into healthcare infrastructure while reimbursement headwinds tighten the margins you have to work with. Watch the 340B proposal closely — comment periods move quickly, and your pharmacy and finance teams need supply chain at the table now.
Quick Hits
- Select Medical is cutting 99 employees, adding to the ongoing wave of healthcare workforce reductions tracked in Modern Healthcare's layoffs and closures log. (Modern Healthcare)
- GE HealthCare's Catholic Health deal also includes an explicit mission to expand access to precision diagnostics across underserved communities in the Long Island region — a factor that may influence future site-level supply planning. (Medical Device Network)
CMS Proposes 2.4% Hospital Outpatient Pay Bump — But 340B Cuts Sting
The proposed 2027 CMS outpatient payment rule offers a modest 2.4% pay increase for hospitals, but buries a significant reduction in pharmaceutical reimbursements for the 340B Drug Pricing Program. For supply chain leaders, this directly pressures drug acquisition strategy and the financial logic behind high-cost specialty drug contracts. If finalized, expect tighter scrutiny on formulary decisions and renewed pressure to optimize 340B-eligible purchasing volumes.
UPS Invests $48M in Temperature-Controlled Transit Facilities
UPS is committing $48 million to expand short-term temperature-controlled storage hubs designed to bridge air-to-ground handoffs while maintaining cold-chain integrity — a persistent weak point in pharmaceutical and biologic logistics. For hospital and ASC supply chain managers sourcing temperature-sensitive products like biologics, vaccines, or cell and gene therapies, this signals improved last-mile reliability from a major carrier. It's a quiet but meaningful infrastructure build that could reduce spoilage risk and improve SLA performance on critical shipments.
Source: Healthcare Purchasing News
GE HealthCare Signs $500M, 10-Year Deal with Catholic Health on Long Island
GE HealthCare and Catholic Health have inked a decade-long, $500M strategic alliance to modernize imaging, AI diagnostics, and precision health capabilities across more than 40 sites on Long Island. For supply chain professionals, large-scale sole-source technology alliances like this shift device procurement from transactional to strategic — reducing competitive bidding leverage but potentially improving service standardization and integration. It's a model other health systems are watching as they weigh long-term vendor partnerships against portfolio flexibility.
Tariffs and Geopolitics Are Squeezing Metals and Plastics Markets
Commodity experts at the Supply Chain Outlook event flagged four key pressure points where tariffs and geopolitical friction are disrupting metals and plastics markets — both critical inputs for medical devices and disposable supplies. The future of USMCA is also in play, which matters for any health system sourcing products manufactured or assembled in Mexico or Canada. Supply chain teams should be stress-testing vendor contracts for commodity pass-through clauses and accelerating conversations with GPOs about pricing protections.
Source: Supply Chain Dive - Healthcare
J&J MedTech Posts $8.9B Q2 on Cardiovascular Strength, Raises FY26 Outlook
Johnson & Johnson reported Q2 revenues of $25.3B, with MedTech contributing $8.9B — growth driven largely by the Shockwave intravascular lithotripsy system and the broader cardiovascular portfolio. A raised full-year outlook signals confidence in procedure volume recovery and device demand, which has downstream implications for pricing leverage in cardiovascular category contracts. Supply chain teams renegotiating J&J agreements this cycle should expect the company to come to the table from a position of strength.
Source: Medical Device Network
DePuy Synthes Acquires Expanding Innovations to Bolster Complex Spine Portfolio
DePuy Synthes has acquired Expanding Innovations, adding interbody cage systems designed for complex spinal surgery to its already substantial spine portfolio. Consolidation in the spine device market continues to reduce the number of independent vendors, which can complicate competitive bidding for orthopedic service lines. Supply chain leaders managing spine implant contracts should assess whether current agreements with DePuy cover these newly acquired SKUs or require renegotiation.
Source: Medical Device Network
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe